首页> 外文期刊>Drug Design, Development and Therapy >Adjuvant Vaginal Use of Sildenafil Citrate in a Hormone Replacement Cycle Improved Live Birth Rates Among 10,069 Women During First Frozen Embryo Transfers
【24h】

Adjuvant Vaginal Use of Sildenafil Citrate in a Hormone Replacement Cycle Improved Live Birth Rates Among 10,069 Women During First Frozen Embryo Transfers

机译:Sildenafil在激素替代循环中柠檬酸盐的辅助阴道使用在第一次冷冻胚胎转移期间提高了10,069名女性中的活产率

获取原文
       

摘要

Purpose:To investigate the effects of sildenafil citrate (SC) on live birth rates (LBR) during women undergoing their first frozen embryo transfers (FET) with hormone replacement therapy (HRT).Patients and Methods:This retrospective cohort study included a total of 10,069 infertile women with adequate endometrial thickness (≥7 mm when progesterone was initiated) in their first FET cycle with hormone replacement therapy. Women received either vaginal SC or no adjuvant during their first transfer cycle depending on patient or physician preference. In the sildenafil group, 1098 women underwent HRT FET with adjuvant vaginal use of SC, and 8971 women were included as controls. The primary outcome measure was LBR, defined as the likelihood of live birth per transfer cycle. Endometrial thickness (EMT), implantation, chemical pregnancy, clinical pregnancy, miscarriage, ongoing pregnancy, birth weight and preterm delivery (PTB) were also recorded.Results:Baseline characteristics were comparable between the two groups. In the crude analysis, the unadjusted LBR was significantly higher in the vaginal SC group (scHRT-FET) than in the control group (HRT-FET) (40.3% vs 36.1%). After adjustment for 12 pregnancy-related confounding factors, logistic regression analysis showed that LBR remained signi?cantly higher in the scHRT-FET group than in the HRT-FET group (adjusted odds ratio [aOR] 1.31, 95% confidence interval [CI] 1.14-1.49). Furthermore, after adjustment, the ongoing pregnancy rate was signi?cantly higher (aOR 1.29, 95% CI 1.13-1.47), and the miscarriage rate was signi?cantly lower (aOR 0.58, 95% CI 0.43-0.77), in the scHRT-FET group compared to the HRT-FET group. Adjuvant vaginal use of SC did not increase the endometrial thickness and had no significant effect on birth weight or PTB.Conclusion:Adjuvant vaginal use of SC in HRT FET was associated with higher LBR and improved pregnancy outcomes in an infertile population with adequate endometrial thickness. The beneficial effect of SC may be due not to an increase in EMT but instead to improve endometrial blood flow and receptivity, which might merit clinicians' attention for improving general IVF practices.? 2020 Tao and Wang.
机译:目的:探讨Sildenafil柠檬酸盐(SC)对具有激素替代疗法(HRT)的女性妇女运动出生率(LBR)对活率(LBR)的影响(HRT)。患者和方法:这项回顾性队列研究总共包括10,069名不育的妇女在其第一个FET循环中具有充足的子宫内膜厚度(≥7mm时),其具有激素替代疗法。根据患者或医生偏好,妇女在第一次转移周期期间接受阴道SC或没有佐剂。在Sildenafil组中,1098名妇女接受了HRT FET的HRT FET,包括SC的佐剂阴道使用,8971名妇女被称为控制。主要结果措施是LBR,定义为每个转移周期的活产的可能性。还记录了子宫内膜厚度(EMT),植入,化学妊娠,临床妊娠,流产,正在进行的妊娠,出生体重和早产(PTB)。结果:两组之间的基线特征是可比的。在粗析分析中,阴道SC组(Schrt-FET)中未调节的LBR显着高于对照组(HRT-FET)(40.3%Vs 36.1%)。在调整12个妊娠相关的混杂因子后,Logistic回归分析表明,LBR仍然存在于Schrt-FET组中的标志(调整后的赔率比[AOR] 1.31,95%置信区间[CI] 1.14-1.49)。此外,在调整后,正在进行的妊娠率是显着的(AOR 1.29,95%CI 1.13-1.47),并且流产率为signi?在SCHRT中,降低(AOR 0.58,95%CI 0.43-0.77),在SCHRT中-FET组与HRT-FET组相比。佐剂阴道使用SC没有增加子宫内膜厚度,对出生体重或PTB没有显着影响。结论:HRT FET中SC的佐剂阴道使用与较高的LBR相关,并且具有足够的子宫内膜厚度的不孕群中的妊娠结果改善。 SC的有益效果可能是由于EMT的增加,而是改善子宫内膜血流和接受,这可能会使临床医生的注意力改善IVF实践。 2020陶和王。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号